Navigation Links
IDEXX Laboratories Announces Fourth Quarter and Full Year Results
Date:1/30/2009

quisition-related purchase Accounting and acquisition integration costs (2) - 1,979 - 2,482 Disposition of pharmaceutical product lines and restructuring(3) - - 1,479 - Discrete income tax benefits(4) - - - - Non-GAAP comparative measurements(5) $529,766 $475,639 $173,935 $148,803 % of revenue 51.7% 51.6% 17.0% 16.1% Twelve Months Ended Earnings per Share Net Income Diluted Dec. 31, Dec. 31, Dec. 31, Dec. 31, 2008 2007 2008 2007 GAAP measurement $116,169 $94,014 $1.87 $1.46 % of revenue 11.3% 10.2% Write-downs of certain Pharmaceutical assets (1) - 6,392 - 0.10 Acquisition-related purchase Accounting and acquisition integration costs (2) - 1,588 - 0.02 Disposition of pharmaceutical product lines and restructuring(3) 3,598 - 0.06 Discrete income tax benefits(4) (1,472) - (0.02) - Non-GAAP comparative measurements(5) $118,295 $101,994 $1.90 $1.58 % of revenue 11.6% 11.1% Management believes adjusted diluted EPS is a useful non-GAAP financial measure to evaluate the results of ongoing operations, excluding significant specified events, period over period, and therefore believes that investors may find this information useful in addition to the GAAP results. We use these supplemental n
'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Names William Brown Corporate Vice President
3. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. IDEXX Laboratories Announces Increase in Share Repurchase Program
6. IDEXX Laboratories Announces Fourth Quarter Results
7. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
8. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
10. Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
11. Metametrix Announces Acquisition of Accu-Chem Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Rochelle, NY, September 17, 2014Diffusion Tensor Imaging (DTI), ... detects microstructural changes in brain tissue, can help ... outcomes following mild traumatic brain injury compared to ... according to a new study published in ... Mary Ann Liebert, Inc., publishers . The ...
(Date:9/17/2014)... CORVALLIS, Ore. People with facial paralysis are perceived ... in the universal language of facial expression, a new ... , The findings highlight the important role the ... hold a prejudice against those with facial paralysis because ... of psychology in the College of Liberal Arts at ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Fasoo ... Security Testing (SAST) tool, at AppSec USA 2014 in ... 9 am to 6 pm at booth G4 inside ... of the leading software security conferences for developers, auditors, ... tool that provides developers and managers with the ability ...
(Date:9/17/2014)... Elsevier, a world-leading provider of scientific, technical and ... publication of a position statement by the European ... Maturitas on the topic of breast ... prevalent cancer in women, with slightly more than ... Mammography screening is a well-established method to detect ...
(Date:9/17/2014)... September 17, 2014 In ongoing ... Inc.’s Drug Benefit News (DBN) continues to find ... in its Aug. 8 issue , CVS Caremark ... lists for 2015 each cut more drugs than ... savings these exclusions are likely to achieve. Despite ...
Breaking Medicine News(10 mins):Health News:New MRI technique helps clinicians better predict outcomes following mild traumatic brain injury 2Health News:Lack of facial expression leads to perceptions of unhappiness, new OSU research shows 2Health News:Lack of facial expression leads to perceptions of unhappiness, new OSU research shows 3Health News:Fasoo to Introduce Their Testing Tool to Improve Software Security and Quality at AppSec USA 2014 2Health News:AIS Newsletter Continues to Find Industry Criticism of PBM Formulary Exclusion Lists 2Health News:AIS Newsletter Continues to Find Industry Criticism of PBM Formulary Exclusion Lists 3
... Netherlands / Rockville, MD, USA (September 22, 2010) ... Exchange: CRX) and the Aeras Global TB Vaccine Foundation ... trial in infants of the jointly developed tuberculosis (TB) ... of the trial is to test the safety and ...
... of Cincinnati (UC) researcher will receive $2.5 million over ... (NIDA) to support his work on a potential immunotherapy ... in the psychiatry and behavioral neuroscience department, is one ... Awards for Innovative Medication Development Research. Award winners receive ...
... HealthDay Reporter , TUESDAY, Sept. 21 (HealthDay ... suicide rates appear to be highest among residents of ... fresh research points to a possible explanation: high altitudes. ... and the high prevalence of gun ownership, may contribute ...
... therapies against cancer to be effective, scientists need to ... makes a cancer cell resistant to a drug and ... Lombardi Comprehensive Cancer Center and Fox Chase Cancer Center. ... , the investigators discuss how cancer cells activate a ...
... of Rhode Island Hospital, is the recipient of the ... Imaging Network (ACRIN). Dupuy received the award for leading ... (RFA) to reduce the pain of osseous metastases (cancer ... scientific paper published during the previous year that stands ...
... Physicians now have access to real time radiology ... Viewbox (patent pending) is a portable interface system ... specialist consultation to physicians using any internet-ready device. ... in transmitting patient information and offers a timely ...
Cached Medicine News:Health News:Aeras and Crucell announce Phase II clinical trial start in Kenya 2Health News:Aeras and Crucell announce Phase II clinical trial start in Kenya 3Health News:Aeras and Crucell announce Phase II clinical trial start in Kenya 4Health News:Researcher wins $2.5 million award from National Institute on Drug Abuse 2Health News:Is High Altitude Linked to Suicide Risk? 2Health News:Is High Altitude Linked to Suicide Risk? 3Health News:Targeted therapy triggers complex mechanism of resistance 2Health News:Targeted therapy triggers complex mechanism of resistance 3Health News:Targeted therapy triggers complex mechanism of resistance 4Health News:Rhode Island Hospital physician receives national award for research 2Health News:Virtual Viewbox offers portable radiology access for physicians 2
(Date:9/17/2014)... Sept. 17, 2014  The law firm McElroy, ... that it will serve as host for "Show ... the Risks of Healthcare Reform," a one-day conference ... delivery systems, reimbursement, compliance and enforcement in a ... Logo -  http://photos.prnewswire.com/prnh/20140916/146606 Logo -  ...
(Date:9/17/2014)... and LEIPZIG, Germany ... announced that it has entered into an exclusive ... development of antibody-based imaging agents to image CD4+ ... collaboration with Novotectid expands ImaginAb,s capability to precisely diagnose ... and autoimmune disease areas. The ability to image ...
(Date:9/17/2014)... LAWRENCEVILLE, N.J. , Sept. 17, 2014 /PRNewswire-USNewswire/ ... that details how to implement GS1 Standards to ... (DSCSA), and enhance patient safety and security in ... Applying GS1 Standards to U.S. Pharmaceutical Supply ... Chain Security Act , was developed in ...
Breaking Medicine Technology:Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4
... part of the eighth annual DVT (deep-vein thrombosis) Awareness Month, ... of DVT and its risk factors among patients with co-morbid ... respiratory and obesity patients.   DVT remains the ... deaths may be due to PE (pulmonary embolism).(1)  This is ...
... Ill., March 9, 2011 Hospira, Inc. (NYSE: ... announced U.S. Food and Drug Administration (FDA) approval of docetaxel. ... Hospira expects to launch the product later this month. ... variety of cancers. In 2010, U.S. sales of Taxotere were ...
Cached Medicine Technology:Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 2Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 3Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism 4Hospira Announces U.S. Approval of Generic Docetaxel 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: